Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Desensitization in normal and neoplastic human thyroid cell lines

S S al-Sobhi1, E Y Soh, M G Wong

  • 1Department of Endocrine Surgery, University of California San Francisco/Mount Zion Medical Center 94143-1674, USA.

World Journal of Surgery
|May 23, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.

BMC nephrology·2018
Same author

PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.

British journal of cancer·2015
Same author

Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells.

Diabetologia·2013
Same author

Comparison of endoscopic and robotic thyroidectomy.

Annals of surgical oncology·2010
Same author

Incidence and clinical behavior of papillary thyroid carcinoma in renal allograft recipients: a single center experience.

Transplantation proceedings·2008
Same author

Invasion of metastatic human follicular thyroid cancer is inhibited via antagonism of protein kinase C.

Cancer letters·2008

Normal thyroid cells show greater desensitization to thyroid-stimulating hormone (TSH) than papillary thyroid cancer cells. This difference in cAMP response may explain why thyroid tumors grow even with suppressed TSH levels.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Papillary thyroid cancers can progress despite suppressed thyroid-stimulating hormone (TSH) levels.
  • The cellular response of normal and cancerous thyroid tissue to repeated TSH stimulation is not fully understood.

Purpose of the Study:

  • To investigate whether desensitization to TSH occurs in normal and neoplastic human thyroid tissue.
  • To compare the extent of TSH desensitization between normal thyroid cells and papillary thyroid cancer cells from the same patients.

Main Methods:

  • Cultured normal and papillary thyroid cancer cells from the same patients.
  • Measured cyclic adenosine monophosphate (cAMP) production and cell growth in response to varying doses of TSH.
  • Assessed the cAMP response to a second TSH stimulus to determine the degree of desensitization.

Related Experiment Videos

Main Results:

  • Both normal and neoplastic thyroid cells responded to TSH with increased cAMP production and growth in a dose-dependent manner.
  • Normal thyroid cells exhibited significant TSH desensitization (up to 75% decrease in cAMP response) in all cultures.
  • Neoplastic thyroid cells showed minimal desensitization (up to 17% decrease in cAMP response), occurring in only two of five cultures.

Conclusions:

  • Normal thyroid tissue demonstrates significantly greater TSH desensitization compared to neoplastic thyroid tissue.
  • The reduced desensitization in thyroid cancer cells may contribute to their sustained growth under fluctuating TSH levels.
  • These findings highlight a potential mechanism underlying thyroid tumor progression in the presence of suppressed TSH.